Benefits of Omega–3 Fish Oil Softgels
Key Findings
Omega-3 fatty acid supplementation, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), is associated with a reduced risk of cardiovascular events and can lower triglyceride levels by 15-50% [1] [2] [3].
These supplements are effective in reducing depressive symptoms in adults with Major Depressive Disorder (MDD), with a pooled effect size of Hedge’s g = −0.45 [4].
Omega-3s contribute to anti-inflammatory effects by modulating inflammatory mediators and supporting immune function [5] [3].
Introduction
Omega-3 fatty acids, including EPA and DHA, are essential polyunsaturated fatty acids primarily found in marine sources like fish oil. These compounds are recognized for their significant roles in various physiological functions, offering benefits across cardiovascular, neurological, and inflammatory health [6] [3] [2]. The provided supplement contains 1000mg of fish oil, with 120mg DHA and 180mg EPA, along with 10mg (83% RI*) of vitamin E (D-alpha-tocopheryl acetate).
Cardiovascular and Metabolic Health
Omega-3 fatty acids, specifically EPA and DHA, play a crucial role in cardiovascular health by modulating lipid metabolism, reducing inflammation, and improving endothelial and platelet function [7] [8] [5]. Several large controlled trials, involving 32,000 participants, have demonstrated that omega-3 supplementation can lead to reductions in cardiovascular events ranging from 19% to 45% [1]. For individuals with hypertriglyceridemia, doses of 3 to 4 g/d of DHA and EPA can lower triglyceride levels by 20% to 50% [1]. A randomized controlled trial involving 8179 patients, mostly with coronary heart disease, found that 4 grams/day of purified EPA reduced the risk for major adverse cardiovascular events by 25% [9]. Another meta-analysis of EPA trials showed a higher reduction in the relative risk of cardiovascular outcomes for EPA compared to EPA + DHA [10].
Neurological and Mental Health
Omega-3 supplementation has shown efficacy in improving neurological and mental health. A systematic review and meta-analysis of twenty studies (15 RCTs and 5 observational studies) with 2,300 participants concluded that omega-3 supplementation significantly reduced depressive symptoms in adults with MDD, with a pooled effect size of Hedge’s g = −0.45 [4]. This effect was more pronounced in individuals with moderate-to-severe depressive symptoms, and EPA supplementation was particularly effective when combined with antidepressants [4]. Additionally, omega-3s, including DHA, are essential for early brain development and have shown benefits in dementia and other neuropsychiatric disorders [11] [12].
Anti-inflammatory and Immune Support
EPA and DHA are known for their potent anti-inflammatory and immunomodulatory effects. They influence the production of pro-inflammatory mediators and promote the resolution of inflammation by generating specialized pro-resolving lipid mediators [5]. These fatty acids enhance the phagocytic capacity of macrophages and improve T-cell and B-cell function, supporting overall immune health [5].
Conclusions
Omega-3 fish oil supplements, particularly those containing EPA and DHA, offer significant health benefits, primarily in cardiovascular health, mental well-being, and inflammation modulation. They are effective in reducing cardiovascular event risk and lowering triglyceride levels, and have demonstrated efficacy in alleviating depressive symptoms in adults with MDD. The anti-inflammatory properties of omega-3s also contribute to overall immune function. The provided supplement, containing 180mg EPA and 120mg DHA, aligns with beneficial dosages for these effects, though higher doses may be recommended for specific conditions like hypertriglyceridemia [1].
References:
1) JH Lee et al. Omega-3 fatty acids for cardioprotection. Mayo Clinic proceedings (2008). https://pubmed.ncbi.nlm.nih.gov/18316000/
2) Zuzanna Kukla et al. Omega-3 Acid and Their impact in Health, review of Existing Knowledge. Quality in Sport (2025). https://apcz.umk.pl/QS/article/view/58193
3) Damian Machaj et al. Omega-3 Fatty Acids and Health. A Literature Review. Quality in Sport (2025). https://apcz.umk.pl/QS/article/view/60187
4) Oluwatobi Idowu et al. The Efficacy of Omega-3 Fatty Acid Supplementation for Major Depressive Disorder in Adults: A Systematic Review and Meta-Analysis. BJPsych Open (2025). https://www.cambridge.org/core/journals/bjpsych-open/article/efficacy-of-omega3-fatty-acid-supplementation-for-major-depressive-disorder-in-adults-a-systematic-review-and-metaanalysis/6B3A44FD884FDB46845606564420AD16
5) M. H. et al. The Role of Omega-3 Fatty Acids in Inflammation and Immune Function. IDOSR JOURNAL OF BIOLOGY CHEMISTRY AND PHARMACY (2024). https://www.idosr.org/the-role-of-omega-3-fatty-acids-in-inflammation-and-immune-function/
6) ÁA Vergara Nieto et al. Molecular Features, Effective Sources, and Physiological Effects of Omega-3 Unsaturated Fatty Acids on Cardiovascular, Neurological, and Muscular Health, and Clinical Relevance for Several Conditions: A Narrative Review. Nutrition reviews (2025). https://pubmed.ncbi.nlm.nih.gov/41189116/
7) I Djuricic et al. N-3 Fatty Acids (EPA and DHA) and Cardiovascular Health - Updated Review of Mechanisms and Clinical Outcomes. Current atherosclerosis reports (2025). https://pubmed.ncbi.nlm.nih.gov/41247613/
8) EL O'Keefe et al. Sea Change for Marine Omega-3s: Randomized Trials Show Fish Oil Reduces Cardiovascular Events. Mayo Clinic proceedings (2019). https://pubmed.ncbi.nlm.nih.gov/31627938/
9) Pietro Gareri et al. Omega-3 Long-Chain Polyunsaturated Fatty Acids in the Elderly: A Review. OBM Geriatrics (2022). https://www.lidsen.com/journals/geriatrics/geriatrics-06-02-198
11) A Goel et al. Fish, Fish Oils and Cardioprotection: Promise or Fish Tale?. International journal of molecular sciences (2018). https://pubmed.ncbi.nlm.nih.gov/30469489/
12) F Shahidi et al. Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits. Annual review of food science and technology (2018). https://pubmed.ncbi.nlm.nih.gov/29350557/